Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
作者信息
Mao Cheng-Yuan, Wu Ping, Zhang Shu-Yu, Yang Jing, Liu Yu-Tao, Zuo Chuan-Tao, Zhuang Zheng-Ping, Shi Chang-He, Xu Yu-Ming
机构信息
Department of Neurology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450000, Henan, China; Institute of Clinical Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Zhengzhou 450000, Henan, China.
PET Centre, Department of Nuclear Medicine, Huashan Hospital, Shanghai Medical College, Fudan University, Shanghai, China.
出版信息
J Neurol Sci. 2016 Oct 15;369:303-305. doi: 10.1016/j.jns.2016.08.042. Epub 2016 Aug 21.
PMID:27653913
Abstract
摘要
相似文献
1
Brain glucose metabolism changes in Parkinson's disease patients with CHCHD2 mutation based on (18)F-FDG PET imaging.
J Neurol Sci. 2016 Oct 15;369:303-305. doi: 10.1016/j.jns.2016.08.042. Epub 2016 Aug 21.
2
CHCHD2 gene mutations in familial and sporadic Parkinson's disease.
Neurobiol Aging. 2016 Feb;38:217.e9-217.e13. doi: 10.1016/j.neurobiolaging.2015.10.040. Epub 2015 Nov 6.
3
A novel mutation of CHCHD2 p.R8H in a sporadic case of Parkinson's disease.
Parkinsonism Relat Disord. 2017 Jan;34:66-68. doi: 10.1016/j.parkreldis.2016.10.018. Epub 2016 Oct 24.
4
Mutation analysis of CHCHD2 in Canadian patients with familial Parkinson's disease.
Neurobiol Aging. 2016 Feb;38:217.e7-217.e8. doi: 10.1016/j.neurobiolaging.2015.10.038. Epub 2015 Nov 6.
5
Analysis of CHCHD2 gene in familial Parkinson's disease from Calabria.
Neurobiol Aging. 2017 Feb;50:169.e5-169.e6. doi: 10.1016/j.neurobiolaging.2016.10.022. Epub 2016 Oct 21.
6
Data-driven identification of intensity normalization region based on longitudinal coherency of F-FDG metabolism in the healthy brain.
Neuroimage. 2017 Feb 1;146:589-599. doi: 10.1016/j.neuroimage.2016.09.031. Epub 2016 Sep 28.
7
Genetic analysis of CHCHD2 and CHCHD10 in Italian patients with Parkinson's disease.
Neurobiol Aging. 2017 May;53:193.e7-193.e8. doi: 10.1016/j.neurobiolaging.2016.12.027. Epub 2017 Jan 5.
8
Diagnostic value of brain MRI and 18F-FDG PET in the differentiation of Parkinsonian-type multiple system atrophy from Parkinson's disease.
Eur J Neurol. 2008 Oct;15(10):1043-9. doi: 10.1111/j.1468-1331.2008.02235.x. Epub 2008 Aug 20.
9
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Neurobiol Aging. 2019 Mar;75:38-41. doi: 10.1016/j.neurobiolaging.2018.10.020. Epub 2018 Oct 23.
10
Metabolic Imaging in Parkinson Disease.
J Nucl Med. 2017 Jan;58(1):23-28. doi: 10.2967/jnumed.116.183152. Epub 2016 Nov 22.
引用本文的文献
1
Impaired microglial glycolysis promotes inflammatory responses after intracerebral haemorrhage via HK2-dependent mitochondrial dysfunction.
J Adv Res. 2024 Aug 13. doi: 10.1016/j.jare.2024.08.016.
2
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson's Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia.
Int J Mol Sci. 2019 Feb 20;20(4):908. doi: 10.3390/ijms20040908.
3
CHCHD10 is involved in the development of Parkinson's disease caused by CHCHD2 loss-of-function mutation p.T61I.
Neurobiol Aging. 2019 Mar;75:38-41. doi: 10.1016/j.neurobiolaging.2018.10.020. Epub 2018 Oct 23.
4
New Genes Causing Hereditary Parkinson's Disease or Parkinsonism.
Curr Neurol Neurosci Rep. 2017 Sep;17(9):66. doi: 10.1007/s11910-017-0780-8.
Zotero 插件